Glenn F. King
Glenn F. King
Professor, Institute for Molecular Bioscience
Verified email at imb.uq.edu.au - Homepage
TitleCited byYear
The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms
BG Fry, K Roelants, DE Champagne, H Scheib, JDA Tyndall, GF King, ...
Annual Review of Genomics and Human Genetics 10, 483-511, 2009
5002009
Venoms as a platform for human drugs: translating toxins into therapeutics
GF King
Expert Opinion on Biological Therapy 11, 1469-1484, 2011
3402011
Spider-venom peptides: structure, pharmacology, and potential for control of insect pests
GF King, MC Hardy
Annual Review of Entomology 58, 475-496, 2013
2432013
Membrane localization of MinD is mediated by a C-terminal motif that is conserved across eubacteria, archaea, and chloroplasts
TH Szeto, SL Rowland, LI Rothfield, GF King
Proceedings of the National Academy of Sciences USA 99, 15693-15698, 2002
2122002
Spider-venom peptides as therapeutics
NJ Saez, S Senff, JE Jensen, SY Er, V Herzig, LD Rash, GF King
Toxins 2, 2851-2871, 2010
2022010
Were arachnids the first to use combinatorial peptide libraries?
BL Sollod, D Wilson, O Zhaxybayeva, JP Gogarten, R Drinkwater, GF King
Peptides 26, 131-139, 2005
1992005
A rational nomenclature for naming peptide toxins from spiders and other venomous animals
GF King, MC Gentz, P Escoubas, GM Nicholson
Toxicon 52, 264-276, 2008
1982008
The structure of a novel insecticidal neurotoxin, ω-atracotoxin-HV1, from the venom of an Australian funnel web spider
JI Fletcher, R Smith, SI O'Donoghue, M Nilges, M Connor, MEH Howden, ...
Nature Structural Biology 4, 559-566, 1997
1961997
Venom landscapes: mining the complexity of spider venoms via a combined cDNA and mass spectrometric approach
P Escoubas, B Sollod, GF King
Toxicon 47, 650-663, 2006
1922006
Discovery and characterization of a family of insecticidal neurotoxins with a rare vicinal disulfide bridge.
X Wang, M Connor, R Smith, MW Maciejewski, MEH Howden, ...
Nature Structural Biology 7, 505–513, 2000
1842000
Venomics: a new paradigm for natural products-based drug discovery
I Vetter, JL Davis, LD Rash, R Anangi, M Mobli, PF Alewood, RJ Lewis, ...
Amino Acids 40, 15-28, 2011
1682011
Macromolecular NMR spectroscopy for the non‐spectroscopist
AH Kwan, M Mobli, PR Gooley, GF King, JP Mackay
FEBS Journal 278, 687-703, 2011
1582011
Venomics as a drug discovery platform
P Escoubas, GF King
Expert Review of Proteomics 6, 221-224, 2009
1532009
ArachnoServer 2.0, an updated online resource for spider toxin sequences and structures
V Herzig, DLA Wood, F Newell, PA Chaumeil, Q Kaas, GJ Binford, ...
Nucleic Acids Research 39, D653-D657, 2011
1522011
Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads
JK Klint, S Senff, DB Rupasinghe, SY Er, V Herzig, GM Nicholson, ...
Toxicon 60, 478-491, 2012
1512012
Discovery of a selective Nav1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models
S Yang, Y Xiao, D Kang, J Liu, Y Li, EAB Undheim, JK Klint, M Rong, ...
Proceedings of the National Academy of Sciences USA 110, 17534-17539, 2013
1502013
Australian funnel-web spiders: master insecticide chemists
HW Tedford, BL Sollod, F Maggio, GF King
Toxicon 43, 601-618, 2004
1472004
The MinD membrane targeting sequence is a transplantable lipid-binding helix
TH Szeto, SL Rowland, CL Habrukowich, GF King
Journal of Biological Chemistry 278, 40050-40056, 2003
1382003
Spider-venom peptides as bioinsecticides
MJ Windley, V Herzig, SA Dziemborowicz, MC Hardy, GF King, ...
Toxins 4, 191-227, 2012
1372012
Measuring protein self-association using pulsed-field-gradient NMR spectroscopy: application to myosin light chain 2
AJ Dingley, JP Mackay, BE Chapman, MB Morris, PW Kuchel, BD Hambly, ...
Journal of Biomolecular NMR 6, 321-328, 1995
1351995
The system can't perform the operation now. Try again later.
Articles 1–20